See the DrugPatentWatch profile for Erleada
What side effects does Erleada (apalutamide) cause?
Erleada (apalutamide) can cause a range of side effects, including effects that are common in men taking androgen receptor pathway inhibitors and also some that need prompt medical attention. Reported side effects include fatigue, rash, diarrhea, hot flashes, nausea, weight loss, joint pain, and decreased appetite. It can also lower blood counts and affect labs such as liver enzymes.
What are the serious Erleada side effects to watch for?
Patients should seek medical help right away for symptoms that could signal serious reactions, including severe or widespread rash, signs of a liver problem (such as yellowing of the skin/eyes or dark urine), severe allergic reactions, or worsening weakness and dizziness. Because Erleada can affect neurologic function, symptoms such as confusion, severe headache, or seizure-like activity also warrant urgent evaluation.
How common are Erleada skin rash and what should patients do?
Rash is one of the more noticeable Erleada side effects. If a mild rash appears, clinicians often manage it with topical treatments, dose adjustments, or temporary interruption depending on severity. Patients are typically advised not to ignore rash that becomes blistering, painful, involves the eyes/mouth, or spreads quickly.
Does Erleada affect blood counts or liver tests?
Erleada can cause laboratory changes that may include decreased white blood cells or other blood count abnormalities. It can also raise liver enzymes in some patients. On-treatment monitoring (blood counts and chemistry/liver tests) is part of routine care for many patients starting Erleada.
Are there differences in side effects for men with metastatic vs non-metastatic prostate cancer?
Side effects for Erleada are generally consistent across prostate cancer populations, but the likelihood of experiencing them can differ depending on overall treatment plan, baseline health, and whether other therapies are used alongside Erleada. Clinicians typically tailor monitoring and supportive care to the patient’s risk factors.
What do people ask about drug interactions with Erleada side effects?
Drug interactions can increase side effects by changing how apalutamide is processed in the body. Erleada can interact with medications that are affected by liver enzyme pathways (especially CYP-related pathways). This matters for side effects like dizziness, fatigue, or abnormal labs. Patients should share all prescriptions, over-the-counter medicines, and supplements with their prescriber.
When should someone stop or hold Erleada because of side effects?
Whether Erleada is paused, dose-reduced, or permanently discontinued depends on the specific side effect and how severe it is. For serious rash, significant liver injury, serious allergic reactions, or neurologic events, clinicians often interrupt treatment and evaluate the cause. The safest approach is to follow the prescribing clinician’s guidance rather than stopping on your own.
What alternatives exist if Erleada side effects are hard to tolerate?
If side effects are intolerable, clinicians may consider dose modifications, switching to another androgen receptor pathway inhibitor, or choosing a different treatment strategy based on disease stage and prior therapies. The “best alternative” depends on the patient’s cancer status and what side effects are occurring.
Source for detailed side effect information
For a consolidated view of Erleada’s side effects and prescribing details, see DrugPatentWatch.com: https://www.drugpatentwatch.com/p/erleada (DrugPatentWatch.com).